BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19648279)

  • 1. Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection.
    Sun JC; Ma A; Lanier LL
    J Immunol; 2009 Sep; 183(5):2911-4. PubMed ID: 19648279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral infection transiently reverses activation receptor-mediated NK cell hyporesponsiveness in an MHC class I-independent mechanism.
    Mazumdar B; Bolanos FD; Tripathy SK
    Eur J Immunol; 2013 May; 43(5):1345-55. PubMed ID: 23440763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct and overlapping patterns of cytokine regulation of thymic and bone marrow-derived NK cell development.
    Cheng M; Charoudeh HN; Brodin P; Tang Y; Lakshmikanth T; Höglund P; Jacobsen SE; Sitnicka E
    J Immunol; 2009 Feb; 182(3):1460-8. PubMed ID: 19155493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-Mediated Activation of NK Cells during Viral Infection.
    Freeman BE; Raué HP; Hill AB; Slifka MK
    J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.
    Nguyen KB; Salazar-Mather TP; Dalod MY; Van Deusen JB; Wei XQ; Liew FY; Caligiuri MA; Durbin JE; Biron CA
    J Immunol; 2002 Oct; 169(8):4279-87. PubMed ID: 12370359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory cytokine signaling required for the generation of natural killer cell memory.
    Sun JC; Madera S; Bezman NA; Beilke JN; Kaplan MH; Lanier LL
    J Exp Med; 2012 May; 209(5):947-54. PubMed ID: 22493516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection.
    Geurs TL; Zhao YM; Hill EB; French AR
    J Immunol; 2009 Nov; 183(9):5830-6. PubMed ID: 19828630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection.
    Min-Oo G; Lanier LL
    J Exp Med; 2014 Dec; 211(13):2669-80. PubMed ID: 25422494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells.
    Parikh BA; Piersma SJ; Pak-Wittel MA; Yang L; Schreiber RD; Yokoyama WM
    PLoS Pathog; 2015 Dec; 11(12):e1005323. PubMed ID: 26720279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection.
    Pien GC; Satoskar AR; Takeda K; Akira S; Biron CA
    J Immunol; 2000 Nov; 165(9):4787-91. PubMed ID: 11046000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections.
    French AR; Sjölin H; Kim S; Koka R; Yang L; Young DA; Cerboni C; Tomasello E; Ma A; Vivier E; Kärre K; Yokoyama WM
    J Immunol; 2006 Oct; 177(8):4981-90. PubMed ID: 17015680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection.
    Dixon KJ; Siebert JR; Wang D; Abel AM; Johnson KE; Riese MJ; Terhune SS; Tarakanova VL; Thakar MS; Malarkannan S
    Mol Immunol; 2021 Sep; 137():94-104. PubMed ID: 34242922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection.
    Nabekura T; Gotthardt D; Niizuma K; Trsan T; Jenus T; Jonjic S; Lanier LL
    J Immunol; 2017 Sep; 199(5):1567-1571. PubMed ID: 28760883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection.
    Arapović J; Arapović M; Golemac M; Traven L; Tomac J; Rumora D; Ražić E; Krmpotić A; Jonjić S
    Med Microbiol Immunol; 2015 Jun; 204(3):335-44. PubMed ID: 25809566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection.
    Nabekura T; Girard JP; Lanier LL
    J Immunol; 2015 Jun; 194(12):5948-52. PubMed ID: 25926677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155.
    Zawislak CL; Beaulieu AM; Loeb GB; Karo J; Canner D; Bezman NA; Lanier LL; Rudensky AY; Sun JC
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6967-72. PubMed ID: 23572582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
    Rowley J; Monie A; Hung CF; Wu TC
    J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection.
    Dorner BG; Smith HR; French AR; Kim S; Poursine-Laurent J; Beckman DL; Pingel JT; Kroczek RA; Yokoyama WM
    J Immunol; 2004 Mar; 172(5):3119-31. PubMed ID: 14978118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.